Phage-based target discovery and its exploitation towards novel antibacterial molecules.

Wan, Xing; Hendrix, Hanne; Skurnik, Mikael; Lavigne, Rob

Wan, Xing; Hendrix, Hanne; Skurnik, Mikael; Lavigne, Rob.

Afiliação

Wan X; Laboratory of Gene Technology, Department of Biosystems, KU Leuven, 3001 Leuven, Belgium; Department of Bacteriology and Immunology, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland; Department of Microbiology, Faculty of Agriculture and Forestr
Hendrix H; Laboratory of Gene Technology, Department of Biosystems, KU Leuven, 3001 Leuven, Belgium.
Skurnik M; Department of Bacteriology and Immunology, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland; Division of Clinical Microbiology, HUSLAB, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland. Electronic address: mikael.
Lavigne R; Laboratory of Gene Technology, Department of Biosystems, KU Leuven, 3001 Leuven, Belgium. Electronic address: rob.lavigne@kuleuven.be.

Curr Opin Biotechnol ; 68: 1-7, 2021 04.

Article em En | MEDLINE | ID: mdl-33007632

Assuntos

Bacteriófagos; Terapia por Fagos; Antibacterianos; Bactérias/genética; Bacteriófagos/genética; Evolução Biológica

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bacteriófagos / Terapia por Fagos Idioma: En Revista: Curr Opin Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google